Dr. Ludwig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1959 Ne Pacific St
Box 356410
Seattle, WA 98195Phone+1 206-543-3687- Is this information wrong?
Education & Training
- University of WashingtonResidency, Surgery, 2013 - 2018
- The University of Texas Health Science Center at San AntonioClass of 2013
Certifications & Licensure
- WA State Medical License 2013 - 2025
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma.Kevin P Labadie, Adrienne L Lehnert, Aimee L Kenoyer, Donald K Hamlin, Andrew D Ludwig, Alan F Utria, Sara K Daniel, Tara N Mihailovic, Alexander Prossnitz, Johnnie J ...> ;EJNMMI Research. 2023 Apr 27
- 6 citationsGlypican-3 targeted thorium-227 alpha therapy reduces tumor burden in an orthotopic xenograft murine model of hepatocellular carcinoma.Kevin P. Labadie, Donald K. Hamlin, Aimee L. Kenoyer, Sara K. Daniel, Alan F. Utria, Andrew D. Ludwig, Heidi L. Kenerson, Lily Li, Jonathan G. Sham, Delphine L. Chen, ...> ;Journal of Nuclear Medicine. 2021 Nov 12
- 6 citationsGlypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinomaKevin P. Labadie, Andrew D. Ludwig, Adrienne L. Lehnert, Donald K. Hamlin, Aimee L. Kenoyer, Kevin M. Sullivan, Sara K. Daniel, Tara N. Mihailovic, Jonathan G. Sham, J...> ;Scientific Reports. 2021 Feb 12
- Join now to see all
Hospital Affiliations
- EvergreenHealthKirkland, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: